High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer

Abstract Background Programmed death ligand 1 (PD‐L1) inhibitor has been approved as one of the standard therapies for various cancers. Some reports have shown that serum PD‐L1 level is associated with advanced tumor stages and poor prognosis; however, corresponding pathological information in esoph...

Full description

Bibliographic Details
Main Authors: Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Kimihiko Funahashi, Naobumi Tochigi, Hideaki Shimada
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Cancer Medicine
Subjects:
biomarker
esophageal cancer
overall survival
serum PD‐L1
Online Access:https://doi.org/10.1002/cam4.2789

Similar Items

Similar Items